| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8215311 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 24 Pages |
Abstract
PORT-first strategy after surgery appeared not to compromise the clinical outcomes in the treatment of stage IIIA-N2 NSCLC. The benefit of POCT on OS was preserved even in the PORT-first setting. Further studies are warranted to compare the sequencing of PORT and POCT, guaranteeing the proper use of POCT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Hyun Woo MD, O Kyu MD, PhD, Young-Taek MD, PhD, Jin-Hyuk MD, PhD, Mison MD, PhD, Hwan-Ik MD, Jaesung MD, MS, Mi Sun MD, MS, Seong Yong MD, MS, Rae Woong MD, PhD, Dukyong MD, MS,